Global Migraine Aid

About Global Migraine Aid

Global Migraine Aid collaborates with local healthcare providers in low- and middle-income countries to train them in delivering safe, effective generic migraine medications. The initiative addresses the critical lack of access to treatment for over one billion individuals suffering from migraines, particularly in regions where less than 1% of patients receive basic care.

```xml <problem> Migraine sufferers in low- and middle-income countries (LMICs) often lack access to even basic, affordable medications, leaving over one billion individuals without adequate treatment. This lack of access results in preventable pain, reduced mental health, and lost productivity, impacting both individuals and the economies of LMICs. Less than 1% of migraine patients in LMICs receive basic medical care. </problem> <solution> Global Migraine Aid addresses the global migraine burden by collaborating with healthcare, religious, industrial, NGO, and governing organizations in LMICs. The organization trains local healthcare providers to deliver safe and effective generic migraine medications. By increasing the availability of affordable treatments, Global Migraine Aid aims to reduce preventable pain, improve mental health, and increase the GDP of LMICs. </solution> <features> - Training programs for local healthcare providers in LMICs on migraine diagnosis and treatment protocols. - Sourcing and distribution of safe, effective generic migraine medications at affordable prices, potentially free to the patient. - Partnerships with healthcare, religious, industrial, NGO, and governing organizations to expand reach and impact. </features> <target_audience> The primary beneficiaries are migraine sufferers in low- and middle-income countries, with a focus on women of working age, and local healthcare providers in those regions. </target_audience> ```

What does Global Migraine Aid do?

Global Migraine Aid collaborates with local healthcare providers in low- and middle-income countries to train them in delivering safe, effective generic migraine medications. The initiative addresses the critical lack of access to treatment for over one billion individuals suffering from migraines, particularly in regions where less than 1% of patients receive basic care.

Where is Global Migraine Aid located?

Global Migraine Aid is based in Atlanta, United States.

When was Global Migraine Aid founded?

Global Migraine Aid was founded in 2024.

Location
Atlanta, United States
Founded
2024
Employees
1 employees
Looking for specific startups?
Try our free semantic startup search

Global Migraine Aid

Score: 1/100
AI-Generated Company Overview (experimental) – could contain errors

Executive Summary

Global Migraine Aid collaborates with local healthcare providers in low- and middle-income countries to train them in delivering safe, effective generic migraine medications. The initiative addresses the critical lack of access to treatment for over one billion individuals suffering from migraines, particularly in regions where less than 1% of patients receive basic care.

globalmigraineaid.org4 followers
Founded 2024 – Atlanta, United States

Funding

No funding information available. Click "Fetch funding" to run a targeted funding scan.

Team (<5)

No team information available. Click "Fetch founders" to run a focused founder search.

Company Description

Problem

Migraine sufferers in low- and middle-income countries (LMICs) often lack access to even basic, affordable medications, leaving over one billion individuals without adequate treatment. This lack of access results in preventable pain, reduced mental health, and lost productivity, impacting both individuals and the economies of LMICs. Less than 1% of migraine patients in LMICs receive basic medical care.

Solution

Global Migraine Aid addresses the global migraine burden by collaborating with healthcare, religious, industrial, NGO, and governing organizations in LMICs. The organization trains local healthcare providers to deliver safe and effective generic migraine medications. By increasing the availability of affordable treatments, Global Migraine Aid aims to reduce preventable pain, improve mental health, and increase the GDP of LMICs.

Features

Training programs for local healthcare providers in LMICs on migraine diagnosis and treatment protocols.

Sourcing and distribution of safe, effective generic migraine medications at affordable prices, potentially free to the patient.

Partnerships with healthcare, religious, industrial, NGO, and governing organizations to expand reach and impact.

Target Audience

The primary beneficiaries are migraine sufferers in low- and middle-income countries, with a focus on women of working age, and local healthcare providers in those regions.